RxDoctor Payments Data

Jessicka Price

Family · Pocatello, IDNPI 1184257818

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (36.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Amgen at 54.1% of the total. Reporting peaked in 2023 at $5,447 and has fallen 90.5% since, to $516 in 2025. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,579in general payments, 2019–2025

Across 122 payments — averaging $86.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$6K
  • Pharmacosmos Therapeutics Inc.$3K
  • Grifols USA, LLC$218
  • Genentech USA, Inc.$200
  • Eisai Inc.$193
  • GSK$128
  • plus $705 from 15 others

What the payments were for

  • Speaking & faculty fees$3,40032%
  • Travel & lodging$3,90637%
  • Food & beverage$3,27331%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,579 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Other family in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →